In this article an infectious diseases and antimicrobial stewardship pharmacist discusses five tips for developing localized antimicrobial stewardship guidelines.  Authored by: Timothy P. Gauthier, Pharm.D, BCPS, BCIDP Article Posted: 12 June 2021 Guidelines for infectious diseases are essential towards directing expected practices and good … [Read more...]

Telehealth has transformed healthcare delivery, including the care of patients with infectious diseases. It can support antimicrobial stewardship efforts and regulatory compliance. Here, three infectious diseases pharmacists weigh in on the topic and identify several things to know about tele-antimicrobial stewardship programs. Authored By: Christina … [Read more...]

In this article two pharmacists discuss what 340B means, providing perspectives and insights on this special program. A discussion between Joe Osborne, Pharm.D. & Christina Rivera, PharmD, BCPS, AAHIV-M Article Posted 25 April 2021 The 340B program often prompts confusion in healthcare professionals given the labyrinth of terminology and the … [Read more...]

In this article Dr. Jeff Boden of of the global branding consultancy Kaleio, Inc. details how ibrexafungerp got its name Authored By: Jeff Boden, Ph.D. Article Posted: 22 April 2021 Ibrexafungerp is a novel antiungal agent that acts as an inhibitor of β(1-3)-glucan-synthase.  The product is differentiated from competitors in the antifungal space … [Read more...]

In this article an infectious diseases pharmacist identifies and discusses five challenges with creating and managing institutional guidelines for infectious diseases.  Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted: 21 April 2021 A recent study published in JAMA assessing the appropriateness of antimicrobial prescribing in … [Read more...]